Polysaccharides from Bupleurum Induce Immune Reversal in Late Sepsis

Polysaccharides from Bupleurum Induce Immune Reversal in Late Sepsis ABSTRACTBackground:Bupleurum chinense, a well-known Traditional Chinese Medicine, has been used for thousands of years in China. In this study, we would suggest that Bupleurum polysaccharides (BPS) could improve the prognosis of sepsis through its impact on redistribution of BMCs, which triggers immune reversal in late sepsis.Methods:BALB/c mice were divided into five groups: sham burn group, burn plus P aeruginosa group, burn plus P aeruginosa with BPS (40 mg/kg, 100 mg/kg, and 250 mg/kg) treatment group, and they were sacrificed at post-burn day (PBD) 0, 3, 5, and 7. BMCs, liver cells, and dendritic cells (DCs) were harvested. Flow cytometry was used to determine the change of phenotypes of DCs and isolate these cells. Cytometric beads array was utilized to analyze the level of inflammatory factors. Cell therapy of BMCs, liver cells, and DCs was administrated to explore the protective role of regional organ immunity.Results:BPS could decrease the lethality of burn sepsis in a dose-dependent fashion and increase both the percentage of CD11c-CD45RBhigh DCs in bone marrow (BM) and liver and the number of BMCs and liver cells significantly. Cell therapy of BMCs, liver cells, and CD11c-CD45RBhigh DCs at PBD7 could protect septic mice from sepsis.Conclusion:BPS has shown its potential in promoting the prognosis of post-burn sepsis through its effect on immune redistribution of BMCs, especially via differentiation of CD11c-CD45RBhigh DC cells in BM and nonimmune organs to induce immune reversal in late sepsis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches Wolters Kluwer Health

Loading next page...
 
/lp/wolters_kluwer/polysaccharides-from-bupleurum-induce-immune-reversal-in-late-sepsis-QJCSKqivJt
Publisher
Wolters Kluwer Health
Copyright
Copyright © 2017 by the Shock Society
ISSN
1073-2322
eISSN
1540-0514
D.O.I.
10.1097/SHK.0000000000000934
Publisher site
See Article on Publisher Site

Abstract

ABSTRACTBackground:Bupleurum chinense, a well-known Traditional Chinese Medicine, has been used for thousands of years in China. In this study, we would suggest that Bupleurum polysaccharides (BPS) could improve the prognosis of sepsis through its impact on redistribution of BMCs, which triggers immune reversal in late sepsis.Methods:BALB/c mice were divided into five groups: sham burn group, burn plus P aeruginosa group, burn plus P aeruginosa with BPS (40 mg/kg, 100 mg/kg, and 250 mg/kg) treatment group, and they were sacrificed at post-burn day (PBD) 0, 3, 5, and 7. BMCs, liver cells, and dendritic cells (DCs) were harvested. Flow cytometry was used to determine the change of phenotypes of DCs and isolate these cells. Cytometric beads array was utilized to analyze the level of inflammatory factors. Cell therapy of BMCs, liver cells, and DCs was administrated to explore the protective role of regional organ immunity.Results:BPS could decrease the lethality of burn sepsis in a dose-dependent fashion and increase both the percentage of CD11c-CD45RBhigh DCs in bone marrow (BM) and liver and the number of BMCs and liver cells significantly. Cell therapy of BMCs, liver cells, and CD11c-CD45RBhigh DCs at PBD7 could protect septic mice from sepsis.Conclusion:BPS has shown its potential in promoting the prognosis of post-burn sepsis through its effect on immune redistribution of BMCs, especially via differentiation of CD11c-CD45RBhigh DC cells in BM and nonimmune organs to induce immune reversal in late sepsis.

Journal

SHOCK®: Injury, Inflammation, and Sepsis: Laboratory and Clinical ApproachesWolters Kluwer Health

Published: Apr 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off